https://www.selleckchem.com/pr....oducts/blasticidin-s
Objective For the first time, we administered reversing prism exposure to treat optic ataxia in a single patient with Balint-Holmes Syndrome (BHS), who also underwent specific trainings for simultanagnosia and ocular apraxia.Method and Results By an introduction and withdrawal experimental design, we observed that the active treatment periods improved patient's visuospatial defects and functional autonomy.Conclusions We thus provided a proof of principle supporting the use of reversing prism exposure in optic ataxia within an
Like
Comment
Share
